NVO stock · LLY stock · Lician Pro · $19.99/mo or $149/yr
NVO vs LLY
Novo Nordisk A S (NVO) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Novo Nordisk A S (NVO) common stock.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
NVO does not have a complete income-statement cache yet.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 42.0.
LLY currently screens at market cap $991.62B and trailing P/E 42.0.
Not investment advice. Open the NVO and LLY stock pages for the full models.
Basic comparison
Price, market cap, and trailing P/E stay on this page.
| Metric | NVO | LLY |
|---|---|---|
| Price | $39.22 | $1251.61 |
| Market cap | — | $991.62B |
| Trailing P/E | — | 42.0 |
Deeper peer metrics
Net income and multi-year revenue growth are the peek. More peer metrics open below. This block stops at the labels.
| Metric | NVO | LLY |
|---|---|---|
| Net income | Pro | Pro |
| Revenue growth | Pro | Pro |
More peer metrics
Operating margin, EPS, free cash flow, and gross margin are on Pro.
NVO vs LLY comparison FAQ
What is LLY's market cap?
Eli Lilly and Company (LLY) currently screens at market cap $991.62B.
What is LLY's P/E ratio?
Eli Lilly and Company (LLY) screens at trailing P/E 42.0.
What is LLY's latest revenue?
Latest reported LLY revenue for 2025-12-31 was $65.18B.
What is LLY's net income?
Net income was $20.64B for Eli Lilly and Company (LLY).
How did LLY revenue change on this page?
Revenue was up 44.7% from 2024-12-31 to 2025-12-31.
How many NVO vs LLY comparison scalars are listed on this page?
This page lists 5 cached comparison scalars for NVO vs LLY: LLY market cap, LLY trailing P/E, LLY revenue, LLY net income, and LLY revenue change.
Where is the NVO vs LLY comparison listed?
The cached NVO vs LLY comparison is listed at https://lician.com/compare/nvo-vs-lly.
Not investment advice.